We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$8.36B
AUM Growth
+$811M
Cap. Flow
+$509M
Cap. Flow %
6.08%
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.59%
2 Technology 14.57%
3 Financials 13%
4 Industrials 11.45%
5 Healthcare 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLDD icon
1901
DELISTED
Great Lakes Dredge & Dock
GLDD
$80K ﹤0.01%
+12,982
New +$72.3K
2018 Q3
0 quarters
HDSN icon
1902
Hudson Technologies
HDSN
$165M
$77K ﹤0.01%
60,539
+39,173
+183% +$69.4K
2018 Q2
1 quarter
ICON icon
1903
DELISTED
Iconix Brand Group
ICON
$75K ﹤0.01%
24,018
+19,530
+435% +$88.2K
2018 Q1
2 quarters
OTIC
1904
DELISTED
Otonomy
OTIC
$73K ﹤0.01%
+26,385
New +$84.7K
2018 Q3
0 quarters
ADMA icon
1905
ADMA Biologics
ADMA
$2.92B
$72K ﹤0.01%
11,600
+554
+5% +$3.19K
2018 Q2
1 quarter
DX icon
1906
Dynex Capital
DX
$2.55B
$72K ﹤0.01%
3,747
-2,153
-36% -$41.4K
2017 Q3
4 quarters
ORMP icon
1907
Oramed Pharmaceuticals
ORMP
$155M
$71K ﹤0.01%
+14,500
New +$75.3K
2018 Q3
0 quarters
DHX icon
1908
DHI Group
DHX
$159M
$69K ﹤0.01%
+32,833
New +$69.2K
2018 Q3
0 quarters
GNE icon
1909
Genie Energy
GNE
$475M
$69K ﹤0.01%
+12,761
New +$71.1K
2018 Q3
0 quarters
NM
1910
DELISTED
Navios Maritime Holdings
NM
$69K ﹤0.01%
9,696
+7,483
+338% +$62.5K
2018 Q2
1 quarter
FNJN
1911
DELISTED
Finjan Holdings
FNJN
$69K ﹤0.01%
+15,981
New +$66.9K
2018 Q3
0 quarters
LUMO icon
1912
DELISTED
Lumos Pharma
LUMO
$65K ﹤0.01%
3,024
-1,867
-38% -$56.8K
2017 Q4
3 quarters
MCF
1913
DELISTED
Contango Oil & Gas
MCF
$64K ﹤0.01%
+10,300
New +$61.1K
2018 Q3
0 quarters
NGNE icon
1914
Neurogene
NGNE
$459M
$62K ﹤0.01%
1,060
-1,158
-52% -$68.3K
2018 Q1
2 quarters
IVAC icon
1915
DELISTED
Intevac
IVAC
$62K ﹤0.01%
11,956
-2,238
-16% -$11.4K
2018 Q2
1 quarter
RIBT
1916
DELISTED
RiceBran Technologies
RIBT
$62K ﹤0.01%
+2,148
New +$60K
2018 Q3
0 quarters
RLGT icon
1917
Radiant Logistics
RLGT
$430M
$60K ﹤0.01%
+10,200
New +$44.9K
2018 Q3
0 quarters
ATNM icon
1918
Actinium Pharmaceuticals
ATNM
$33M
$57K ﹤0.01%
2,540
+1,797
+242% +$36.6K
2018 Q2
1 quarter
CHK icon
1919
DELISTED
Chesapeake Energy
CHK
$54K ﹤0.01%
60
-296
-83% -$270K
2017 Q4
3 quarters
ISEE
1920
DELISTED
IVERIC bio
ISEE
$50K ﹤0.01%
+21,300
New +$53.1K
2018 Q3
0 quarters
ELGX
1921
DELISTED
Endologix
ELGX
$50K ﹤0.01%
2,634
+595
+29% +$21.2K
2018 Q1
2 quarters
AGEN icon
1922
Agenus
AGEN
$270M
$48K ﹤0.01%
1,148
-2,399
-68% -$94.4K
2016 Q4
7 quarters
SN icon
1923
DELISTED
Sanchez Energy
SN
$42K ﹤0.01%
+18,126
New +$62.6K
2018 Q3
0 quarters
CFMS
1924
DELISTED
Conformis
CFMS
$40K ﹤0.01%
1,491
+1,067
+252% +$29K
2018 Q2
1 quarter
HL icon
1925
Hecla Mining
HL
$7.07B
$39K ﹤0.01%
+13,815
New +$42.2K
2018 Q3
0 quarters

Similar funds

Squarepoint's Q3 2018 Portfolio in Review

As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Squarepoint deployed $509M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.

  • Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
  • Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
  • Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
  • Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
  • Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
  • Squarepoint opened 687 new positions and closed 456 in Q3 2018.
  • Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.

Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.